Action GMO International Qualit...

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Dernier

25,0984

Prix Achat

Prix Vente

Volume échangé

82 595

24,85 Fourchette du Jour 25,07

22,49 Plage de 52 semaines 25,46

Clôture Veille

24,88

Ouverture

24,98

Dernière Transaction

100

25.0984

Dernière heure de transaction

Volume moyen (3 m)

12 328

Volume financier

US$ 2 061 492

VWAP

24,959

QLT Inc. establishes sales force in the United States

- QLT Ophthalmics, Inc. will market Visudyne(R) to retinal specialists across the U.S.- VANCOUVER, Dec. 22 /PRNewswire-FirstCall/ -- QLT Inc...

QLT initiates Phase Ib study of QLT091001 in Leber Congenital Amaurosis

VANCOUVER, Dec. 15 /PRNewswire-FirstCall/ -- QLT Inc. (NASDAQ: QLTI; TSX: QLT) ("QLT" or the "Company") today announced that it has initiated...

6-month results from EVEREST study evaluating Visudyne(R) therapy in patients with polypoidal choroidal vasculopathy

VANCOUVER, Dec. 9 /PRNewswire-FirstCall/ -- QLT Inc. (NASDAQ: QLTI; TSX: QLT) ("QLT" or the "Company") welcomed the 6-month results from the...

QLT announces MGH litigation settlement

VANCOUVER, Nov. 25 /PRNewswire-FirstCall/ -- QLT Inc. (NASDAQ: QLTI; TSX: QLT) ("QLT" or the "Company") today announced the settlement of its...

QLT announces Toronto Stock Exchange approval of share repurchase program

VANCOUVER, Oct. 28 /PRNewswire-FirstCall/ -- QLT Inc. (NASDAQ: QLTI; TSX: QLT) ("QLT") announced that the Toronto Stock Exchange ("TSX") has...

QLT Announces Share Repurchase Program

VANCOUVER, Oct. 27 /PRNewswire-FirstCall/ -- QLT Inc. (NASDAQ: QLTI; TSX: QLT) ("QLT" or the "Company") today announced that its board of...

QLT announces third quarter results for 2009

QLT SEPARATELY ANNOUNCES SHARE REPURCHASE PROGRAM VANCOUVER, Oct. 27 /PRNewswire-FirstCall/ -- QLT Inc. (NASDAQ: QLTI; TSX: QLT) ("QLT" or the...

QLT restructures Visudyne(R) agreement

RECEIVES EXCLUSIVE U.S. RIGHTS AND WILL RECEIVE A ROYALTY ON SALES OUTSIDE THE U.S. VANCOUVER, Oct. 19 /PRNewswire-FirstCall/ -- QLT Inc...

QLT announces sale of QLT USA, Inc. for up to US$230 million

VANCOUVER, Oct. 1 /PRNewswire-FirstCall/ -- QLT Inc. (NASDAQ: QLTI; TSX: QLT) ("QLT" or the "Company") today announced that it has completed the...

QLT announces receipt of a CDN$45.3 million tax refund

VANCOUVER, Sept. 8 /PRNewswire-FirstCall/ -- QLT Inc. (NASDAQ: QLTI; TSX: QLT) ("QLT" or the "Company") today announced that it has received an...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0.9384	3.88410596026	24.16	25.28	24.15	10753	24.80764532	SP
4	0.2184	0.877813504823	24.88	25.35	23.95	6951	24.5344591	SP
12	1.3934	5.87808479224	23.705	25.46	22.49	12328	23.5917539	SP
26	0.2484	0.999597585513	24.85	25.46	22.49	11426	23.6831292	SP
52	0.2484	0.999597585513	24.85	25.46	22.49	11426	23.6831292	SP
156	0.2484	0.999597585513	24.85	25.46	22.49	11426	23.6831292	SP
260	0.2484	0.999597585513	24.85	25.46	22.49	11426	23.6831292	SP

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

GMO International Quality ETF (QLTI)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

QLTI Dernières nouvelles

QLT Inc. establishes sales force in the United States

QLT initiates Phase Ib study of QLT091001 in Leber Congenital Amaurosis

6-month results from EVEREST study evaluating Visudyne(R) therapy in patients with polypoidal choroidal vasculopathy

QLT announces MGH litigation settlement

QLT announces Toronto Stock Exchange approval of share repurchase program

QLT Announces Share Repurchase Program

QLT announces third quarter results for 2009

QLT restructures Visudyne(R) agreement

QLT announces sale of QLT USA, Inc. for up to US$230 million

QLT announces receipt of a CDN$45.3 million tax refund

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

GMO International Quality ETF (QLTI) Cours

GMO International Quality ETF (QLTI)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

QLTI Dernières nouvelles

QLT Inc. establishes sales force in the United States

QLT initiates Phase Ib study of QLT091001 in Leber Congenital Amaurosis

6-month results from EVEREST study evaluating Visudyne(R) therapy in patients with polypoidal choroidal vasculopathy

QLT announces MGH litigation settlement

QLT announces Toronto Stock Exchange approval of share repurchase program

QLT Announces Share Repurchase Program

QLT announces third quarter results for 2009

QLT restructures Visudyne(R) agreement

QLT announces sale of QLT USA, Inc. for up to US$230 million

QLT announces receipt of a CDN$45.3 million tax refund

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités